{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:25:43Z","timestamp":1792531543514,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ypmed.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T03:42:23Z","timestamp":1539229343000},"page":"44-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results"],"prefix":"10.1016","volume":"118","author":[{"given":"Philip E.","family":"Castle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Poitras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Lorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard D.","family":"Strickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ypmed.2018.10.001_bb0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European guidelines for quality assurance in cervical cancer screening. Second edition\u2013summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ypmed.2018.10.001_bb0010","doi-asserted-by":"crossref","first-page":"djt460","DOI":"10.1093\/jnci\/djt460","article-title":"Early impact of human papillomavirus vaccination on cervical neoplasia\u2013nationwide follow-up of young Danish women","volume":"106","author":"Baldur-Felskov","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.ypmed.2018.10.001_bb0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"5","key":"10.1016\/j.ypmed.2018.10.001_bb0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1309\/PT3PNC1QL2F4D2VL","article-title":"The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses:an ALTS report","volume":"127","author":"Castle","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"issue":"10 Suppl","key":"10.1016\/j.ypmed.2018.10.001_bb0025","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/cncr.23762","article-title":"Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United States","volume":"113","author":"Castle","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ypmed.2018.10.001_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/lgt.0b013e31815ea58b","article-title":"Risk assessment to guide the prevention of cervical cancer","volume":"12","author":"Castle","year":"2008","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ypmed.2018.10.001_bb0035","doi-asserted-by":"crossref","first-page":"g1458","DOI":"10.1136\/bmj.g1458","article-title":"Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia","volume":"348","author":"Crowe","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2018.10.001_bb0040","first-page":"10","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"14","author":"Drolet","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.ypmed.2018.10.001_bb0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5858\/134.3.331","article-title":"Practices of participants in the college of american pathologists interlaboratory comparison program in cervicovaginal cytology, 2006","volume":"134","author":"Eversole","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"11","key":"10.1016\/j.ypmed.2018.10.001_bb0050","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/ijc.25940","article-title":"Impact of an HPV6\/11\/16\/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16\/18 infection","volume":"129","author":"Haupt","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"5 Suppl 1","key":"10.1016\/j.ypmed.2018.10.001_bb0055","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/LGT.0b013e318285423c","article-title":"Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines","volume":"17","author":"Katki","year":"2013","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"5 Suppl 1","key":"10.1016\/j.ypmed.2018.10.001_bb0060","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/LGT.0b013e3182854253","article-title":"Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results","volume":"17","author":"Katki","year":"2013","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"5 Suppl 1","key":"10.1016\/j.ypmed.2018.10.001_bb0065","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/LGT.0b013e3182854269","article-title":"Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results","volume":"17","author":"Katki","year":"2013","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"12","key":"10.1016\/j.ypmed.2018.10.001_bb0070","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(17)30468-1","article-title":"Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study","volume":"17","author":"Kavanagh","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.ypmed.2018.10.001_bb0075","doi-asserted-by":"crossref","first-page":"djw216","DOI":"10.1093\/jnci\/djw216","article-title":"Optimal cervical cancer screening in women vaccinated against human papillomavirus","volume":"109","author":"Kim","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.ypmed.2018.10.001_bb0080","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ypmed.2018.10.001_bb0085","doi-asserted-by":"crossref","first-page":"i3633","DOI":"10.1136\/bmj.i3633","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ypmed.2018.10.001_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol."},{"issue":"RR-2","key":"10.1016\/j.ypmed.2018.10.001_bb0095","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.ypmed.2018.10.001_bb0100","author":"Merck"},{"issue":"6","key":"10.1016\/j.ypmed.2018.10.001_bb0105","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ypmed.2018.10.001_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Munoz","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ypmed.2018.10.001_bb0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/bjc.2015.474","article-title":"HPV immunisation and cervical screening\u2013confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study","volume":"114","author":"Palmer","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.10.001_bb0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejca.2017.12.018","article-title":"Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: the value of stratifying guidelines","volume":"91","author":"Pedersen","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.10.001_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ypmed.2013.10.009","article-title":"Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review","volume":"58","author":"Rambout","year":"2014","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2018.10.001_bb0130","doi-asserted-by":"crossref","first-page":"b2968","DOI":"10.1136\/bmj.b2968","article-title":"Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data","volume":"339","author":"Sasieni","year":"2009","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.ypmed.2018.10.001_bb0135","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/1471-0528.13839","article-title":"Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium","volume":"123","author":"Sasieni","year":"2016","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.ypmed.2018.10.001_bb0140","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(08)70110-4","article-title":"Heterogeneity in CIN3 diagnosis","volume":"9","author":"Schiffman","year":"2008","journal-title":"Lancet Oncol."},{"issue":"9590","key":"10.1016\/j.ypmed.2018.10.001_bb0145","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ypmed.2018.10.001_bb0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cncr.10317","article-title":"Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom","volume":"96","author":"Scott","year":"2002","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ypmed.2018.10.001_bb0155","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2352-4642(18)30220-7","article-title":"Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study","volume":"2","author":"Silverberg","year":"2018","journal-title":"Lancet Child Adolesc. Health"},{"issue":"4","key":"10.1016\/j.ypmed.2018.10.001_bb0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"16","key":"10.1016\/j.ypmed.2018.10.001_bb0165","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"issue":"29","key":"10.1016\/j.ypmed.2018.10.001_bb0170","first-page":"620","article-title":"Human papillomavirus vaccination coverage among adolescents, 2007\u20132013, and postlicensure vaccine safety monitoring, 2006\u20132014\u2013United States","volume":"63","author":"Stokley","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"6","key":"10.1016\/j.ypmed.2018.10.001_bb0175","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000381","article-title":"The interpretive variability of cervical biopsies and its relationship to HPV status","volume":"39","author":"Stoler","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ypmed.2018.10.001_bb0180","doi-asserted-by":"crossref","first-page":"k499","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2018.10.001_bb0185","author":"U.S. Preventive Service Task Force"},{"issue":"1","key":"10.1016\/j.ypmed.2018.10.001_bb0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"issue":"16","key":"10.1016\/j.ypmed.2018.10.001_bb0195","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.287.16.2120","article-title":"2001 consensus guidelines for the management of women with cervical cytological abnormalities","volume":"287","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ypmed.2018.10.001_bb0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LGT.0b013e318159408b","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"11","author":"Wright","year":"2007","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"4","key":"10.1016\/j.ypmed.2018.10.001_bb0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright","year":"2007","journal-title":"J. Low. Genit. Tract Dis."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743518303062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743518303062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:02:09Z","timestamp":1758794529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743518303062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":41,"alternative-id":["S0091743518303062"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2018.10.001","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}